指南与共识甲状腺疾病

甲状腺乳头状微小癌的术前与术后风险分层:Kuma标准与2015年美国甲状腺协会指南风险分层的比较研究

Preoperative and Postoperative Risk Stratification of Thyroid Papillary Microcarcinoma: A Comparative Study Between Kuma Criteria and 2015 American Thyroid Association Guidelines Risk Stratification.
指南 / 共识 · Thyroid · 2020-03-11

该研究回顾性分析墨西哥城一家三级医院2000至2018年108例术后病理确诊为甲状腺乳头状微小癌的患者,比较术前Kuma标准与2015年ATA术后复发风险分层。按Kuma标准术前79例(73%)为高风险、29例(27%)为低风险;79例高风险者经ATA标准再分层后38例(48%)为低风险、12例(15%)为中风险、29例(37%)仍为高风险。作者结论认为年龄<40岁和镜下甲状腺外侵犯与转移性疾病风险升高相关。

要点

  • 按Kuma标准术前判为低风险的29例中,8例(27.5%)术后按ATA标准归为高风险。
  • 术前风险特征对淋巴结转移和远处转移的诊断准确率分别为84.2%和97.2%。
  • 多因素分析显示年龄<40岁和镜下甲状腺外侵犯与转移性疾病风险升高相关。

核心结论

  • 作者认为年龄<40岁和镜下甲状腺外侵犯的甲状腺乳头状微小癌患者更易发生转移性疾病(淋巴结或远处)。
  • 按Kuma标准适合主动监测的低风险患者中,约三分之一具有与更具侵袭性临床行为或结构性复发相关的组织病理学特征。
  • 淋巴结转移和远处转移是术前风险分层中诊断准确率最高的术前风险特征。

研究设计与样本

  • 回顾性研究,纳入墨西哥城一家三级医院2000至2018年术后组织病理学确诊为甲状腺乳头状微小癌的108例患者。
  • 分析人口学与临床病理资料作为疾病复发和(或)转移性疾病(淋巴结或远处)的预测因素。
  • 比较基于术前Kuma标准的分层与基于2015年ATA指南术后复发风险标准的分层。
  • 按Kuma标准计算术前风险特征的诊断准确率指标。

主要发现

  • 108例中,按Kuma标准术前79例(73%)为高风险、29例(27%)为低风险。
  • 79例术前高风险者中,按2015年ATA风险标准38例(48%)再归类为低风险、12例(15%)为中风险、29例(37%)仍为高风险。
  • 29例术前低风险者中,19例(65.5%)术后仍为低风险、2例(7%)为中风险、8例(27.5%)为高风险。
  • 术前风险特征对淋巴结转移和远处转移的准确率分别为84.2%和97.2%。
  • 多因素分析显示年龄<40岁和镜下甲状腺外侵犯与本队列转移性疾病(淋巴结或远处)风险升高相关。

关键数值与推荐

  • Kuma标准术前分层:高风险79例(73%),低风险29例(27%)。
  • 2015年ATA术后复发风险分层用于术前Kuma高风险79例:低风险38例(48%)、中风险12例(15%)、高风险29例(37%)。
  • 2015年ATA术后复发风险分层用于术前Kuma低风险29例:低风险19例(65.5%)、中风险2例(7%)、高风险8例(27.5%)。
  • 术前风险特征诊断准确率:淋巴结转移84.2%,远处转移97.2%。

临床怎么用

  • 作者认为年龄<40岁和镜下甲状腺外侵犯的甲状腺乳头状微小癌患者更易发生转移性疾病(淋巴结或远处)。
  • 作者指出按Kuma标准归为主动监测低风险的患者中约三分之一具有与更具侵袭性临床行为或结构性复发相关的组织病理学特征。
  • 作者认为淋巴结转移和远处转移是术前风险分层中诊断准确率最高的术前风险特征。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The incidence of micropapillary thyroid carcinoma (mPTC) has increased in the last decade. Active surveillance (AS) has been proposed as an alternative management for low-risk mPTC based on preoperative Kuma criteria. Controversy still exists on how to appropriately manage this group of patients, as some low-risk mPTC may harbor some postoperative features associated with disease recurrence as described in the 2015 American Thyroid Association (ATA) guidelines. Methods: We retrospectively reviewed 108 patients with histopathologic diagnosis of mPTC after surgery at a third level hospital in Mexico City from 2000 to 2018. Demographic and clinicopathologic data were analyzed as predictors for disease recurrence and/or metastatic disease (lymph node or distant). Comparison between group stratification based on preoperative Kuma criteria and postoperative 2015 ATA guidelines risk criteria for disease recurrence was performed. Measures of diagnostic accuracy were obtained for preoperative risk features according to the Kuma criteria. Results: Of 108 patients, 79 (73%) were classified as preoperative high-risk mPTC and 29 (27%) as low risk based on the Kuma criteria. Of these 79 high-risk patients, 38 (48%) were reclassified as low risk for disease recurrence, 12 (15%) as intermediate risk, and 29 (37%) remained as high risk based on the 2015 ATA risk criteria. Of the 29 preoperative low-risk patients, 19 (65.5%) remained as postoperative low risk for disease recurrence, 2 (7%) as intermediate risk, and 8 (27.5%) as high risk. Higher accuracy of preoperative risk features was obtained for lymph node and distant metastases, 84.2% and 97.2%, respectively. After multivariate analysis, age <40 years and microscopic extrathyroidal extension (ETE) were associated with higher risk for metastatic disease (lymph node or distant) in our cohort. Conclusions: Patients with mPTC under 40 years old and microscopic ETE are more prone to develop metastatic disease (lymph node or distant). One-third of our patients stratified as low-risk mPTC according to the Kuma criteria for AS had histopathologic features associated with a more aggressive clinical behavior or structural recurrence. In addition, lymph node and distant metastases are the preoperative risk features with the highest diagnostic accuracy for preoperative risk stratification.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Pérez-Soto RH, Velázquez-Fernández D, Arellano-Gutiérrez G, et al. Preoperative and Postoperative Risk Stratification of Thyroid Papillary Microcarcinoma: A Comparative Study Between Kuma Criteria and 2015 American Thyroid Association Guidelines Risk Stratification. Thyroid. 2020. PMID: 32031061. doi:10.1089/thy.2019.0698

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。